Tibet Aim Pharm., Inc. (002826) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tibet Aim Pharm., Inc.

Why is Tibet Aim Pharm., Inc. ?

Poor long term growth as Net Sales has grown by an annual rate of 0.17% and Operating profit at 21.03% over the last 5 years

The company has declared Positive results for the last 3 consecutive quarters

ROCE(HY) Highest at 11.69%
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
RAW MATERIAL COST(Y) Fallen by -5.05% (YoY)

With ROE of 11.20%, it has a expensive valuation with a 2.44 Price to Book Value

Over the past year, while the stock has generated a return of -5.19%, its profits have risen by 144.8% ; the PEG ratio of the company is 0.2
At the current price, the company has a high dividend yield of 1.6

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 16.83% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -5.19% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tibet Aim Pharm., Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tibet Aim Pharm., Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Tibet Aim Pharm., Inc.

-13.61%

2.42

48.33%

China Shanghai Composite

3.23%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.17%

EBIT Growth (5y)

21.03%

EBIT to Interest (avg)

36.01

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.60

Sales to Capital Employed (avg)

0.82

Tax Ratio

20.18%

Dividend Payout Ratio

30.00%

Pledged Shares

Institutional Holding

ROCE (avg)

12.95%

ROE (avg)

6.15%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.48

EV to EBIT

30.85

EV to EBITDA

25.92

EV to Capital Employed

11.17

EV to Sales

3.41

PEG Ratio

0.21

Dividend Yield

0.68%

ROCE (Latest)

36.21%

ROE (Latest)

11.20%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 239.31 MM

ROCE(HY)

Highest at 14.95%

RAW MATERIAL COST(Y)

Fallen by 0.18% (YoY

CASH AND EQV(HY)

Highest at CNY 1,332.89 MM

DEBT-EQUITY RATIO (HY)

Lowest at -71.49 %

DEBTORS TURNOVER RATIO(HY)

Highest at 17.94 times

OPERATING PROFIT(Q)

Highest at CNY 32.85 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18.56 %

PRE-TAX PROFIT(Q)

Highest at CNY 58.11 MM

NET PROFIT(Q)

Highest at CNY 47.03 MM

EPS(Q)

Highest at CNY 0.25

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Tibet Aim Pharm., Inc.

Pre-Tax Profit

At CNY 58.11 MM has Grown at 106.36%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 47.03 MM has Grown at 150.66%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 239.31 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Operating Profit

Highest at CNY 32.85 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 18.56 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 58.11 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 47.03 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.25

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 1,332.89 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -71.49 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 17.94 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by 0.18% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Footer loading